A 2007 study that compared spending on pharmaceutical drugs in the U.S. and Canada estimates that if Canada had followed the American lead in allowing these ads, it would be spending $10 billion more per year on prescription medicines than it currently does. This study, combined with a 2005 systematic review that found no evidence that direct-to-consumer advertising leads to health benefits, suggests the costs of opening the door to these less restrictive ads - both in dollars and risks - is not worth the possible benefits, unless they profiled appropriate and cost-effective treatments.
Source:Canadian Health Services Research Foundation
Date published: 09-07

AROUND THE WORLD

General Practice EMRs: What They Can Tell Us, and How

What Constitutes Clinical Data?

NEWS FROM CANADA

Canadian Health IT Agency Funds Telehealth In Native Communities

LATEST IN THE FIELD

An Electronic Health Record Based on Structured Narrative

Making a Better Connection

Get Out the Crystal Ball: Predicting What's Next for Health IT

INDUSTRY SPEAK

Subspecialty EMRs

Early Experiences with Personal Health Records

Computers, Coding, and Change

The Life of a Surgical House Officer - Why Isn't IT Helping Us? Endless Opportunities

INFOWAY UPDATE

Find Out What's New and Happening at Canada Health Infoway

WORTH NOTING

Healthcare Leaders' Dialogue on Governance Renewal

Accelerating Primary Care 2008

Best Practices Day 2008: Using Research Evidence; Advancing Rehabilitation Practice

Evidence Soup for the Policy-Maker's Soul

Integrated Care and the Management of Chronic Illness

Neuroimaging in Dementia

The 5th Annual World Healthcare Congress

Comments

Be the first to comment on this!